CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Quarterly

0 1M 2M 3M Q1 '22: 1.6M Q2 '22: 1.6M Q3 '22: 1.5M Q4 '22: 1.6M Q1 '23: 1.7M Q2 '23: 1.7M Q3 '23: 1.8M Q4 '23: 1.8M Q1 '24: 1.7M Q2 '24: 1.8M Q3 '24: 1.8M Q4 '24: 1.8M Q1 '25: 1.7M Q2 '25: 1.8M Q3 '25: 1.8M Q4 '25: 2.3M Q1 '26: 1.9M Q2 '26: 2M Q3 '26: 2.7M Q4 '26: 2.8M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '22: -3.8M Q2 '22: -4M Q3 '22: -4.9M Q4 '22: -4.6M Q1 '23: -5.4M Q2 '23: -5.7M Q3 '23: -5.9M Q4 '23: -5.5M Q1 '24: -6M Q2 '24: -4.8M Q3 '24: -6.1M Q4 '24: -5.5M Q1 '25: -5.4M Q2 '25: -5.7M Q3 '25: -4.8M Q4 '25: -5M Q1 '26: -6.1M Q2 '26: -5.3M Q3 '26: -6.2M Q4 '26: -4M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-4M -2M 0 2M 4M 6M Q3 '21: 982K Q1 '22: -175K Q2 '22: 263K Q3 '22: 830K Q4 '22: -311K Q1 '23: -284K Q2 '23: 7K Q3 '23: -2.5M Q4 '23: -2.5M Q1 '24: -2.6M Q2 '24: -2M Q3 '24: -2.6M Q4 '24: -271K Q1 '25: 1.3M Q2 '25: 732K Q3 '25: 4.5M Q1 '26: -527K Q2 '26: 185K Q3 '26: -276K Q4 '26: -522K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q1 '26 Q4 '26

Net Income Quarterly

-4M -2M 0 2M 4M 6M Q3 '21: 959K Q1 '22: -172K Q2 '22: 277K Q3 '22: 787K Q4 '22: -344K Q1 '23: -319K Q2 '23: -16K Q3 '23: -2.4M Q4 '23: -2.6M Q1 '24: -2.6M Q2 '24: -2.1M Q3 '24: -2.5M Q4 '24: -109K Q1 '25: 1.3M Q2 '25: 728K Q3 '25: 4.5M Q1 '26: -436K Q2 '26: 268K Q3 '26: -279K Q4 '26: -667K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q1 '26 Q4 '26

Cost of Revenue Quarterly

0 3.5M 7M 10.5M Q1 '22: 5.4M Q2 '22: 5.6M Q3 '22: 6.4M Q4 '22: 6.2M Q1 '23: 7.1M Q2 '23: 7.4M Q3 '23: 7.7M Q4 '23: 7.3M Q1 '24: 7.7M Q2 '24: 6.6M Q3 '24: 7.8M Q4 '24: 7.2M Q1 '25: 7.1M Q2 '25: 7.4M Q3 '25: 6.6M Q4 '25: 7.3M Q1 '26: 8M Q2 '26: 7.3M Q3 '26: 8.8M Q4 '26: 6.8M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating Cash Flow Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q1 '22: 216K Q2 '22: 1.2M Q3 '22: 4.3M Q4 '22: 796K Q1 '23: -195K Q2 '23: 3.3M Q3 '23: 1.6M Q4 '23: -692K Q1 '24: -4M Q2 '24: 589K Q3 '24: -919K Q4 '24: -1.8M Q1 '25: 311K Q2 '25: -283K Q3 '25: 490K Q4 '25: 6.9M Q1 '26: 600K Q2 '26: -1.7M Q3 '26: -1.3M Q4 '26: -2M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Free Cash Flow Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q1 '22: -691K Q2 '22: 662K Q3 '22: 3.9M Q4 '22: 290K Q1 '23: -949K Q2 '23: 2.7M Q3 '23: 819K Q4 '23: -1.5M Q1 '24: -4.7M Q2 '24: 510K Q3 '24: -1M Q4 '24: -1.8M Q1 '25: 311K Q2 '25: -377K Q3 '25: 448K Q4 '25: 6.6M Q1 '26: 554K Q2 '26: -2M Q3 '26: -1.4M Q4 '26: -2.2M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q2 '20: 13M Q3 '20: 13.7M Q1 '21: 14.2M Q2 '21: 15.1M Q3 '21: 14.5M Q1 '22: 13.4M Q2 '22: 14.5M Q3 '22: 14.4M Q1 '23: 13.5M Q2 '23: 13.5M Q3 '23: 13.6M Q1 '24: 13.5M Q2 '24: 13.5M Q3 '24: 13.6M Q1 '25: 14M Q2 '25: 14M Q3 '25: 14.4M Q1 '26: 13.8M Q2 '26: 14.5M Q3 '26: 13.9M Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.75 -0.50 -0.25 0.00 0.25 0.50 0.75 Q1 '19: -0.03 Q2 '19: -0.00 Q3 '19: -0.02 Q4 '19: 0.01 Q1 '20: -0.09 Q2 '20: -0.09 Q3 '21: -0.11 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.01 Q3 '23: -0.22 Q4 '23: -0.39 Q1 '24: -0.56 Q2 '24: -0.71 Q3 '24: -0.72 Q4 '24: -0.54 Q1 '25: -0.26 Q2 '25: -0.06 Q3 '25: 0.44 Q4 '26: -0.07 Q2 '19 Q1 '20 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.